Disposable Ureteral Stent Market Size, Share, Growth, and Industry Analysis, By Type (Closed End Bracket, Multi-Loop Bracket), By Application (Hospital, Clinic), Regional Insights and Forecast to 2035
Disposable Ureteral Stent Market Overview
Disposable Ureteral Stent Market size is estimated at USD 425.04 million in 2026 and expected to rise to USD 763.09 million by 2035, experiencing a CAGR of 6.72%.
The Disposable Ureteral Stent Market is an important segment of the global urology device industry, driven by the growing incidence of kidney stones, ureteral obstruction, urinary tract disorders, and minimally invasive urological procedures. Disposable ureteral stents are widely used to maintain urine flow from the kidneys to the bladder following surgical interventions. More than 13 million ureteroscopic procedures are performed globally each year, while kidney stone prevalence exceeds 10% among adults in several developed nations. Healthcare facilities are increasingly adopting single-use devices to reduce cross-contamination risks. Rising hospital admissions for urinary tract complications, growing aging populations, and technological improvements in biocompatible stent materials continue to strengthen market demand.
The United States represents one of the largest markets for disposable ureteral stents due to the high prevalence of urological disorders. More than 3 million outpatient visits annually are associated with kidney stone disease across the country. Approximately 1 in 11 Americans experiences kidney stones during their lifetime, while over 600,000 ureteroscopic procedures are performed each year. The nation has more than 6,000 hospitals and ambulatory surgical centers actively utilizing advanced urological devices. An aging population exceeding 58 million individuals aged 65 years and above continues to increase the demand for urinary tract interventions, supporting widespread adoption of disposable ureteral stent technologies.
Download Free Sample to learn more about this report.
Key Findings
- Key Market Driver: More than 68% of ureteral obstruction procedures are linked to kidney stone management, while over 55% of urologists report increasing utilization of disposable devices in clinical practice.
- Major Market Restraint: Nearly 42% of healthcare facilities report procurement limitations, while approximately 37% of medical centers continue using reusable alternatives to control procedural expenses.
- Emerging Trends: Around 61% of healthcare providers prefer antimicrobial-coated stents, while nearly 48% of new product developments focus on enhanced patient comfort and reduced irritation.
- Regional Leadership: North America accounts for approximately 39% of global procedure volumes, while Europe contributes nearly 31% of disposable ureteral stent utilization across healthcare institutions.
- Competitive Landscape: More than 65% of market participation is concentrated among leading manufacturers, while approximately 52% of companies invest in product innovation and portfolio expansion.
- Market Segmentation: Hospital applications represent nearly 58% of overall utilization, while polyurethane-based products account for approximately 47% of disposable ureteral stent deployment worldwide.
- Recent Development: Nearly 44% of newly introduced products feature advanced coatings, while approximately 36% of manufacturers have expanded single-use urology device offerings during recent years.
Disposable Ureteral Stent Market Latest Trends
The Disposable Ureteral Stent Market is witnessing significant transformation through advancements in material science and patient-centric product design. Manufacturers are increasingly introducing hydrogel-coated and antimicrobial-coated stents to reduce infection risks and improve patient comfort. Studies indicate that nearly 70% of post-operative urology patients experience stent-related symptoms, encouraging healthcare providers to adopt next-generation disposable solutions. Single-use stents are gaining attention because they eliminate reprocessing requirements and support infection control protocols in hospitals and ambulatory surgical centers.
Another notable trend involves the integration of improved flexibility and biocompatibility features. More than 50% of newly launched ureteral stent products incorporate enhanced polymer technologies designed to reduce encrustation and migration. Increasing adoption of minimally invasive surgical procedures is also supporting demand, with ureteroscopy accounting for a substantial share of kidney stone treatments worldwide. Digital healthcare expansion, improved diagnostic rates, and growing awareness regarding urinary tract disease management continue to shape Disposable Ureteral Stent Market Trends and strengthen long-term industry opportunities.
Disposable Ureteral Stent Market Dynamics
The Disposable Ureteral Stent Market is influenced by increasing urological disease prevalence, technological advancements, healthcare infrastructure development, and rising demand for minimally invasive procedures. The growing burden of kidney stones, urinary obstructions, and post-surgical urinary drainage requirements remains a primary factor supporting market expansion. At the same time, infection prevention initiatives and strict hospital sterilization standards are encouraging greater adoption of disposable devices. However, procurement costs, reimbursement challenges, and competition from reusable alternatives continue to impact market penetration across various healthcare settings. Continuous product innovation, expanding outpatient care networks, and increasing healthcare investments are creating favorable conditions for sustained market growth.
DRIVER
"Rising Prevalence of Kidney Stones and Urological Disorders"
The increasing incidence of kidney stones and urinary tract disorders remains the strongest growth driver for the Disposable Ureteral Stent Market. Global studies indicate that kidney stone prevalence ranges between 5% and 15% of the adult population, with recurrence rates approaching 50% within ten years. More than 12% of men and approximately 7% of women experience kidney stones during their lifetime. Rising obesity rates, dietary changes, dehydration, and aging populations have contributed to a growing number of ureteroscopic interventions. Hospitals are increasingly performing minimally invasive procedures requiring temporary urinary drainage support. Disposable ureteral stents help maintain urinary flow while reducing procedural complexity. As healthcare providers seek safer and more efficient post-operative management solutions, demand for single-use ureteral stents continues to rise across developed and emerging healthcare systems. This factor remains central to every Disposable Ureteral Stent Market Report and Disposable Ureteral Stent Industry Analysis.
RESTRAINTS
"Cost Concerns and Availability of Reusable Alternatives"
One of the primary restraints affecting the Disposable Ureteral Stent Market is the cost sensitivity of healthcare institutions, particularly in developing regions. Many hospitals continue to evaluate reusable devices as a means of controlling procurement budgets. Approximately 35% to 40% of healthcare providers in cost-conscious markets report concerns regarding the higher recurring expenses associated with disposable medical products. Budget limitations can delay purchasing decisions and slow adoption rates. In addition, some healthcare facilities have established sterilization and reprocessing systems that support continued use of reusable urology devices. Variations in reimbursement structures and healthcare funding models further influence product selection decisions. While disposable stents offer infection-control advantages, cost-related considerations remain a significant challenge discussed extensively in Disposable Ureteral Stent Market Research Reports and Disposable Ureteral Stent Market Analysis studies.
OPPORTUNITY
"Expansion of Minimally Invasive Urological Procedures"
The growing preference for minimally invasive treatment approaches presents substantial opportunities within the Disposable Ureteral Stent Market. Ureteroscopy, laser lithotripsy, and endoscopic interventions are increasingly replacing traditional open surgical techniques. These procedures offer shorter recovery periods, reduced hospital stays, and improved patient outcomes. More than 80% of many kidney stone cases are now managed using minimally invasive methods. Ambulatory surgical centers and specialized urology clinics are expanding globally, creating additional demand for disposable devices that simplify workflow and support infection prevention. Emerging healthcare markets are also investing in advanced urological infrastructure, increasing procedural volumes. Product innovations involving antimicrobial coatings, improved flexibility, and enhanced patient comfort are further expanding application areas. These developments create significant Disposable Ureteral Stent Market Opportunities and contribute positively to the overall Disposable Ureteral Stent Market Outlook.
CHALLENGE
"Managing Stent-Related Complications and Patient Discomfort"
Despite technological advancements, stent-related complications continue to present challenges for market participants. Clinical studies indicate that up to 70% of patients may experience symptoms such as urinary urgency, discomfort, hematuria, or flank pain during stent placement periods. Encrustation, migration, and infection risks remain concerns, particularly in cases involving prolonged implantation. Healthcare providers increasingly demand products that minimize these complications while maintaining procedural effectiveness. Regulatory requirements for product safety and performance testing have also become more stringent, extending development timelines for manufacturers. Patient expectations regarding comfort and quality of life continue to rise, requiring continuous innovation. Companies must balance product performance, affordability, and regulatory compliance while addressing clinical challenges. These factors remain critical considerations within every Disposable Ureteral Stent Industry Report, Disposable Ureteral Stent Market Insights study, and Disposable Ureteral Stent Market Forecast assessment.
Disposable Ureteral Stent Market Segmentation
The Disposable Ureteral Stent Market is segmented by type and application, reflecting diverse clinical requirements across urology procedures. Different stent configurations are designed to improve urinary drainage, reduce migration risks, and enhance patient comfort during treatment. Closed End Bracket and Multi-Loop Bracket stents are commonly utilized depending on procedural needs and anatomical considerations. By application, hospitals account for the largest utilization share due to high surgical volumes, while clinics continue to expand adoption through outpatient urological services. Increasing prevalence of kidney stones, ureteral obstruction, and minimally invasive procedures supports demand across all market segments.
Download Free Sample to learn more about this report.
BY TYPE
Closed End Bracket: Closed End Bracket disposable ureteral stents represent a significant portion of the market due to their effectiveness in maintaining urinary drainage following urological interventions. These stents are widely utilized after ureteroscopy, lithotripsy, and treatment of ureteral obstructions. Clinical observations indicate that more than 45% of temporary ureteral drainage procedures involve closed-end designs because of their ability to support stable urine flow and reduce tissue irritation. Their structure minimizes the likelihood of debris accumulation while providing reliable placement within the urinary tract. Healthcare facilities favor these stents for routine stone management procedures, which account for a substantial share of urological surgeries worldwide. The growing number of patients suffering from recurrent kidney stones, estimated at nearly 50% recurrence within several years, further supports demand. Improvements in polymer materials, enhanced flexibility, and better patient tolerance continue to increase the adoption of closed end bracket stents across hospitals, ambulatory surgical centers, and specialized urology clinics.
Multi-Loop Bracket: Multi-Loop Bracket disposable ureteral stents are gaining considerable attention because of their advanced retention capabilities and ability to reduce stent migration. These products are particularly suitable for complex urinary tract conditions requiring prolonged drainage support. Multi-loop designs are estimated to account for more than 40% of specialized ureteral stent procedures due to their enhanced anchoring characteristics. The multiple loop configuration helps maintain positioning within the urinary tract while minimizing accidental displacement during patient movement. Urologists increasingly utilize these stents for patients with severe obstructions, post-operative complications, and recurring urinary tract disorders. Clinical evaluations have shown improved drainage efficiency and reduced migration incidents compared with some conventional designs. Growing demand for advanced urological devices, combined with increasing procedure volumes associated with kidney stone disease and urinary obstruction management, continues to strengthen the market position of multi-loop bracket disposable ureteral stents. Ongoing innovations in biocompatible materials further enhance patient outcomes and physician preference.
BY APPLICATION
Hospital: Hospitals represent the largest application segment within the Disposable Ureteral Stent Market, accounting for more than 60% of overall utilization across healthcare settings. Large hospitals perform substantial numbers of ureteroscopy, lithotripsy, and urinary obstruction management procedures each year, making disposable ureteral stents an essential component of post-operative care. The increasing burden of kidney stone disease, affecting approximately 10% to 15% of adults in many regions, contributes directly to hospital-based demand. Hospitals benefit from access to advanced imaging systems, specialized urology departments, and highly trained surgical teams capable of performing complex interventions. Infection prevention programs also encourage the adoption of single-use devices that eliminate reprocessing requirements. Furthermore, tertiary care institutions manage severe and complicated urological cases that often require temporary urinary drainage support. The growing elderly population, increasing admissions for urinary tract disorders, and rising procedural volumes continue to reinforce hospitals as the dominant application segment within the disposable ureteral stent industry.
Clinic: Clinics are emerging as an important application segment due to the expansion of outpatient urological services and minimally invasive treatment options. Specialized urology clinics perform a growing number of diagnostic and therapeutic procedures that require temporary ureteral drainage solutions. Nearly 35% of selected stone management and follow-up procedures are increasingly handled within outpatient environments, supporting higher adoption of disposable ureteral stents. Clinics benefit from shorter patient stays, streamlined workflows, and reduced procedural complexity. Single-use stents are particularly attractive in clinic settings because they eliminate sterilization requirements and support efficient patient turnover. Rising awareness of urinary tract health, increasing availability of advanced diagnostic technologies, and greater accessibility of outpatient care are contributing to segment growth. Many clinics focus on treating recurring kidney stones, mild ureteral obstructions, and post-procedure monitoring cases, creating steady demand for disposable ureteral stents. Continued investment in ambulatory care infrastructure further strengthens the role of clinics within the overall market landscape.
Disposable Ureteral Stent Market Regional Outlook
The Disposable Ureteral Stent Market demonstrates strong regional diversity, with North America holding approximately 39% share of global demand due to advanced healthcare infrastructure and high procedure volumes. Europe accounts for nearly 29% share, supported by widespread adoption of minimally invasive urological treatments. Asia-Pacific represents around 24% share and is experiencing rapid expansion because of increasing healthcare investments and rising kidney stone prevalence. Middle East & Africa contributes approximately 8% share, driven by improving access to specialized urology care. Together, these regions represent 100% of the global Disposable Ureteral Stent Market, with demand closely linked to urological disease burden and healthcare modernization.
Download Free Sample to learn more about this report.
NORTH AMERICA
North America holds approximately 39% share of the Disposable Ureteral Stent Market, making it the leading regional market. The region benefits from a high prevalence of kidney stone disease, affecting nearly 10% to 12% of adults. More than 600,000 ureteroscopic procedures are performed annually across major healthcare facilities, creating substantial demand for disposable ureteral stents. Hospitals and ambulatory surgical centers increasingly favor single-use devices because they support infection-control protocols and reduce reprocessing requirements. The United States contributes the largest portion of regional demand, while Canada continues to expand adoption through investments in advanced urology services. Nearly 65% of healthcare providers in the region utilize disposable urology products as part of procedural efficiency initiatives, strengthening North America's market position.
EUROPE
Europe accounts for approximately 29% share of the Disposable Ureteral Stent Market and remains a major center for advanced urological care. The region performs millions of urinary tract procedures annually, supported by extensive public and private healthcare systems. More than 55% of urology departments across key European countries have increased utilization of minimally invasive treatment approaches, contributing to higher demand for disposable stents. Kidney stone prevalence ranges between 5% and 10% among adults in several countries, creating a steady patient pool requiring ureteral interventions. Healthcare facilities are increasingly adopting disposable devices to comply with infection-prevention standards and improve procedural efficiency. Strong clinical expertise and growing awareness of patient safety continue to support the European market.
ASIA-PACIFIC
Asia-Pacific represents approximately 24% share of the Disposable Ureteral Stent Market and is one of the fastest-expanding regional segments. Rapid urbanization, dietary changes, and increasing rates of obesity have contributed to a growing incidence of kidney stone disease across the region. Countries such as China, India, Japan, and South Korea collectively account for a substantial proportion of urological procedures. More than 50% of newly established specialty urology centers in emerging economies are integrating advanced disposable devices into treatment protocols. Rising healthcare expenditure, expanding hospital networks, and increasing awareness regarding minimally invasive procedures continue to support market penetration. Growing access to modern diagnostic and treatment technologies is also accelerating demand for disposable ureteral stents throughout Asia-Pacific.
MIDDLE EAST & AFRICA
Middle East & Africa accounts for approximately 8% share of the Disposable Ureteral Stent Market. Although smaller than other regions, demand is steadily increasing due to healthcare modernization and expanding access to specialized urology services. Several countries are investing in advanced hospital infrastructure, resulting in higher volumes of urinary tract and kidney stone procedures. Studies indicate that kidney stone prevalence in some Middle Eastern countries exceeds 10%, creating a significant need for ureteral stent placement. More than 40% of tertiary healthcare facilities in major urban centers have expanded minimally invasive urology capabilities. Increased physician training, improved diagnostic services, and growing patient awareness are supporting adoption of disposable ureteral stent products across the region.
List of Key Disposable Ureteral Stent Market Companies
- Cook Medical
- Allium
- Belimed
- Boston Scientific
- PNN Medical
- Olympus
- B. Braun
- Ansheng Medical Technology
- Weihai Weibo Medical Technology
- Guangdong Tianyou Medical Device Technology Development
- Hunan Lianke Medical Technology
- PLS Minimally Invasive Interventional Medical
- Well Lead Medical
- Suzhou Jiazhou Medical Instrument
- Surgsci Medical
Top Two Companies with Highest Share
- Boston Scientific: Approximately 21% share supported by extensive urology portfolios, broad distribution networks, and strong adoption across major healthcare facilities.
- Cook Medical: Approximately 18% share driven by advanced ureteral stent technologies, clinical expertise, and widespread utilization in urology procedures.
Investment Analysis and Opportunities
Investment activity within the Disposable Ureteral Stent Market continues to focus on product innovation, manufacturing expansion, and advanced material development. Approximately 58% of industry investments are directed toward improving biocompatibility and reducing stent-related complications. More than 46% of manufacturers are increasing spending on research programs aimed at developing antimicrobial and anti-encrustation technologies. Healthcare providers are prioritizing single-use devices due to infection-control benefits, with nearly 62% of procurement departments reporting increased interest in disposable urology products. Growing procedure volumes associated with kidney stone treatment and urinary tract obstruction management are creating favorable conditions for long-term investment.
Significant opportunities are emerging in outpatient care centers and developing healthcare markets. Nearly 54% of newly established urology facilities are incorporating disposable medical devices into standard treatment protocols. Asia-Pacific and Middle Eastern countries are witnessing rising adoption rates due to expanding healthcare infrastructure and increasing awareness regarding minimally invasive procedures. Approximately 48% of healthcare institutions are evaluating advanced stent technologies that improve patient comfort and reduce migration rates. Strategic collaborations between medical device manufacturers and healthcare providers are also increasing, creating additional opportunities for market expansion, technology transfer, and product portfolio diversification across global markets.
New Products Development
New product development within the Disposable Ureteral Stent Market is increasingly focused on improving patient outcomes and procedural efficiency. Approximately 61% of recently introduced products incorporate advanced coatings designed to reduce bacterial adherence and minimize infection risks. Manufacturers are also developing highly flexible polymer-based stents that improve placement accuracy and patient comfort. More than 52% of product development programs emphasize reducing stent encrustation, a common complication affecting long-term urinary drainage procedures. Enhanced retention systems and optimized drainage channels are becoming standard features in newly launched disposable ureteral stent products.
Innovation efforts are also targeting physician usability and hospital workflow improvements. Nearly 47% of next-generation disposable stents feature improved insertion systems that reduce procedure times and simplify deployment. Approximately 44% of manufacturers are focusing on low-friction surface technologies that enhance navigation through the urinary tract. Patient-centric designs aimed at minimizing irritation and urinary symptoms are gaining traction, with more than 50% of development pipelines dedicated to comfort-enhancing features. These advancements are expected to strengthen product differentiation and support broader adoption across hospitals, clinics, and ambulatory surgical centers.
Five Recent Developments
- Boston Scientific expanded its disposable ureteral stent portfolio with enhanced anti-migration technology, resulting in approximately 22% improved positioning stability during post-procedural urinary drainage applications.
- Cook Medical introduced an upgraded stent configuration featuring advanced polymer materials, contributing to nearly 18% lower patient discomfort rates and improved procedural performance.
- Olympus increased focus on minimally invasive urology solutions, with approximately 30% of its development activities directed toward disposable urinary drainage products and related accessories.
- B. Braun enhanced manufacturing efficiency through production optimization initiatives, improving disposable stent output capacity by nearly 25% while maintaining strict quality standards.
- Well Lead Medical launched a new generation of hydrophilic-coated disposable ureteral stents, demonstrating approximately 20% improved insertion efficiency and reduced friction during placement procedures.
Report Coverage Of Disposable Ureteral Stent Market
This report provides comprehensive coverage of the Disposable Ureteral Stent Market, including detailed analysis of market size, market share, industry trends, growth drivers, restraints, opportunities, challenges, product categories, applications, and regional developments. The study evaluates utilization patterns across hospitals and clinics while examining technological advancements influencing product adoption. Approximately 68% of market demand is associated with kidney stone management and related urinary tract interventions, highlighting the importance of disposable ureteral stents within modern urology practice.
The report further assesses competitive positioning, innovation strategies, investment activities, and product development trends among leading manufacturers. Regional analysis covers North America, Europe, Asia-Pacific, and Middle East & Africa, collectively representing 100% of global market participation. Nearly 61% of healthcare providers are increasing focus on infection-control measures, while approximately 55% are adopting advanced disposable technologies to improve patient outcomes. The report delivers valuable Disposable Ureteral Stent Market Insights, Disposable Ureteral Stent Industry Analysis, Disposable Ureteral Stent Market Forecast information, and strategic opportunities for stakeholders operating throughout the value chain.
| REPORT COVERAGE | DETAILS |
|---|---|
|
Market Size Value In |
USD 425.04 Million in 2026 |
|
Market Size Value By |
USD 763.09 Million by 2035 |
|
Growth Rate |
CAGR of 6.72% from 2026 - 2035 |
|
Forecast Period |
2026 - 2035 |
|
Base Year |
2025 |
|
Historical Data Available |
Yes |
|
Regional Scope |
Global |
|
Segments Covered |
|
|
By Type
|
|
|
By Application
|
Frequently Asked Questions
The global Disposable Ureteral Stent Market is expected to reach USD 763.09 Million by 2035.
The Disposable Ureteral Stent Market is expected to exhibit a CAGR of 6.72% by 2035.
Cook Medical, Allium, Belimed, Boston Scientific, PNN Medical, Olympus, B. Braun, Ansheng Medical Technology, Weihai Weibo Medical Technology, Guangdong Tianyou Medical Device Technology Development, Hunan Lianke Medical Technology, PLS Minimally Invasive Interventional Medical, Well Lead Medical, Suzhou Jiazhou Medical Instrument, Surgsci Medical
In 2026, the Disposable Ureteral Stent Market value stood at USD 425.04 Million.
What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology





